Spots Global Cancer Trial Database for Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
Official Title: SSTR2-Targeted PET Imaging of Meningioma: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
Study ID: NCT04298541
Conditions
Study Description
Brief Summary: The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Detailed Description: The investigator is proposing a direct comparison of Ga-68-DOTATATE and -DOTATOC in a pilot cohort of patients with meningioma, and hypothesize non-inferiority of DOTATOC. This pilot study will form the basis for a subsequent prospective clinical trial and will allow us to optimize our existing imaging protocols, while developing a more cost-effective protocol. Primary Objectives: * Optimize the Ga-68-DOTATOC PET/CT protocol. * Compare Ga-68-DOTATATE PET and -DOTATOC PET/CT in patients with meningioma. Secondary Objectives ⢠Correlate Ga-68-DOTATATE PET and -DOTATOC PET/CT with clinical and pathological characteristics
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Weill Cornell Medical College of Cornell University, New York, New York, United States
Contact Details
Name: Jana Ivanidze, MD/Ph.D
Affiliation: Weill Medical College of Cornell University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
